Clinical trial
A Randomized, Safety and Efficacy Study of Taneasy 600mg Granules and Actein Effervescent Tablets 600MG in COPD Subjects
NCT06688292 is registered in ClinicalTrials.gov with Bun Yao Biotechnology Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Safety and Efficacy Study of Taneasy 600mg Granules and Actein Effervescent Tablets 600MG in COPD Subjects
- Lead sponsor
- Bun Yao Biotechnology Co., Ltd
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 20, 2024
- Completion date
- December 31, 2024
- Enrollment
- 42 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
copd (chronic obstructive pulmonary disease)